ClinicalTrials.gg
RecruitingNCT06350656EC2Updated Apr 5, 2024

Study of Cerebral Compliance in Neurosurgical Intensive Care Units (EC2)

An observational study in Cerebrospinal; Disorder, sponsored by Centre Hospitalier Universitaire de Saint Etienne. Recruiting at 7 sites in France. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2024-04-05.

Sponsored by Centre Hospitalier Universitaire de Saint Etienne · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Apr 2024, 2 years 7 months ago, but the record still lists the study as recruiting.
  • Started Mar 2023; still recruiting 3 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
30
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 46 studies in Central Nervous System Diseases with a site in France — 15 open to participants now, 17 under way, 1 of them phase 3. Central Nervous System Diseases · France.

Planned enrollment
9th of 12
30 · median 110
Started
2023
with 7 others
Observational
12 of 46
6 open now
Primary completion
2024-04
later than 1 of 16 live
Registered
35th of 46
by date

Among the 46 studies in Central Nervous System Diseases with a site in France, this one is the 9th largest by planned enrollment of the 12 observational ones that give a count, is one of 8 that started in 2023, is one of 12 observational ones, reaches primary completion later than 1 of the 16 other live ones, and was the 35th registered.

Central Nervous System Diseases

386 studies on the registry are indexed under Central Nervous System Diseases; 104 are open to participants now.

Browse Central Nervous System Diseases studies →

Open to participants now

15 of the 46 studies in Central Nervous System Diseases with a site in France are open now. Recruiting first, the newest first:

9 more — sign in →

All 15 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 76 Central Nervous System Diseases studies recruiting now, 34 (45%) set no upper age limit and 22 (29%) stop at 75 or younger; 10 take children under 18; 12 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 46 studies in Central Nervous System Diseases with a site in France, or all of them as a file.
02

Study summary

Despite the massive use of intracranial pressure in neuro-resuscitation, there is still no cerebral compliance evaluation index used in current practice to guide therapy.

In treatment guidelines for intracranial hypertension, patients are placed in a prone position at about 30 degrees. Several times a day, during nursing care, patients are flattened, which corresponds to a cerebral compliance test by adding a volume of cerebrospinal fluid to the cranial box.

Read the detailed description

This study aims to analyse the shape of the different components of the intracranial pressure waves (P1, P2, and P3) when the patient is flattened to determine an index to define the level of cerebral compliance.

03

Conditions studied

  • Cerebrospinal; Disorder

Keywords

  • Cerebrospinal compliance
  • Intracranial pressure.
  • Head injury
  • Pulse waveform
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Sedated patient on mechanical ventilation with continuous intracranial pressure monitoring

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Continuous intracranial pressure monitoring
  • Sedated patient on mechanical ventilation

Exclusion criteria

Exclusion Criteria:

  • Craniectomy
  • Major hemodynamic failure
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
30 participants (estimated)
Patient registry
No

Interventions

  • OtherClinical data collection

    Post-retrieval from the medical record

  • OtherTherapeutic data collection

    Post-retrieval from the medical record

  • OtherIntraCranial Pression (ICP) values collection

    Post-retrieval of ICP values from the monitor

06

What researchers measure

Primary outcomes

  1. Intracranial pressure (mmHg)

    Intracranial pressure is measured before (Raising the head by 30°) and during the flattening (Raising the head by 0°). Theses measures are done twice a day. The mean of theses values is calculated.

    Time frame: Year : 1

Secondary outcomes

  1. Correlation between ICP (Intra Cranial Pressure) doses and cerebral compliance

    Compare the ICP (Intra Cranial Pressure) dose value with the compliance index during the period before or after the flattening

    Time frame: Year : 1

07

Study locations

7 of 7 sites recruiting
  • CENTRE HOSPITALIER Charponnay
    Chaponnay, 69970, France
    Recruiting
    • PIERRE-HENRI MURGAT, MD · Principal investigator
  • CENTRE HOSPITALIER UNIVERSITAIRE Grenoble
    Grenoble, 38000, France
    Recruiting
    • JEAN FRANCOIS PAYEN, MD · Principal investigator
  • HOPITAL NORD La Tronche
    La Tronche, 38170, France
    Recruiting
    • KEVIN LAGARDE, MD · Principal investigator
  • APHP
    Paris, 75010, France
    Recruiting
    • SAMUEL GAUGUIN, MD · Principal investigator
  • Hopital Lariboisiere - Ahph
    Paris, 75010, France
    Recruiting
    • JEROME CARTAILLIER, MD · Principal investigator
  • CENTRE HOSPITALIER UNIVERSITAIRE Rennes
    Rennes, 35000, France
    Recruiting
    • YOANN LAUNEY, MD PHD · Principal investigator
  • CENTRE HOSPITALIER UNIVERSITAIRE Saint-Etienne
    Saint-Étienne, 42055, France
    Recruiting
    • CLEMENT MAGAND, MD · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2023 (actual). Primary completion is estimated for Apr 2024, 13 months after the start.

Of 39 observational studies under Central Nervous System Diseases, half reached primary completion within 67 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 121. This study's planned 13 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 31, 2023
First posted
Apr 5, 2024
StartActual
Mar 31, 2023
Primary completionEst.
Apr 2024
CompletionEst.
Apr 2024
Last update
Apr 5, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06350656
Responsible party
Sponsor
First posted
Apr 5, 2024
Start date
Mar 31, 2023
Primary completion
Apr 2024 (estimated)
Completion
Apr 2024 (estimated)
Last update
Apr 5, 2024

Study contacts

LAURENT GERGELE, MD
Contact
laurent.gergele@chu-st-etienne.fr
(0)477828593 ext. +33
LAURENT GERGELE, MD
principal investigator · CHU DE SAINT-ETIENNE

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion